Marie-Julie Nokin

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

April, 2025

Marie-Julie Nokin

Dec 16, 2024, 23:31 | Insight

Anirban Maitra: Preclinical studies in lung cancer using a KRAS G12V directed PROTAC

Anirban Maitra, Professor of Pathology and Translational Molecular Pathology at UT MD Anderson Cancer Center, shared…

Sep 6, 2024, 13:28 | Insight

Biagio Ricciuti: How adaptive mechanisms and increased GTP loading confer resistance to KRAS G12C OFF

Biagio Ricciuti shared on X: “Our in Nature Communications our collaborative effort showing how adaptive mechanisms…

Aug 12, 2024, 06:16 | Insight

Biagio Ricciuti: In vivo vulnerabilities to GPX4 and HDAC inhibitors in BRAF V600E lung adenocarcinoma

Biagio Ricciuti shared a post on LinkedIn about his recent paper, commenting: “Our collaborative effort…

Aug 12, 2024, 02:37 | Blog

Biagio Ricciuti: Vulnerabilities to GPX4 and HDAC inhibitors in BRAF V600E lung adenocarcinoma

Biagio Ricciuti posted on X about recent paper by Marie-Julie Nokin et al., titled "In…

All: 4 Posts: 1 - 100

'

Karen Knudsen has been appointed as the CEO of the Parker Institute for Cancer Immunotherapy

'

Highlights from ELCC 2025

'

FDA Approved Pluvicto (177Lu-PSMA-617) for Metastatic Castration-Resistant Prostate Cancer

'

Meet the New AACR Board of Directores for 2025-2028 Term

'

Do Artificial Sweeteners Cause Cancer? Myths and Facts

Special Coverage

Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023